With Telezen MD, the most useful question is not simply whether a plan starts at $99 a month. It is what happens after you pay: who reviews your history, which pharmacy fills a prescription, when another charge could occur, and what money remains refundable if treatment does not proceed. The platform publishes substantial information about these steps, but some of its clearest marketing promises sit beside narrower—or conflicting—policy provisions.
This documentary review examines Telezen MD’s public pages consulted October 19, 2026, from a prospective patient’s perspective. The documented business connects U.S. adults with licensed healthcare professionals and prescription fulfillment, prominently advertising compounded injectable semaglutide and tirzepatide. Its named credentials and pharmacy standards are provider statements, not independently verified findings here. The goal is to turn the available details into practical questions, while distinguishing a published service offering from a prescription guarantee, a clinical outcome or a refundable purchase.
At a glance
- Standard semaglutide pricing
- Compounded injectable semaglutide is advertised at $168 billed monthly or $297 every three months, presented as $99 per month for the quarterly option.Sources: [11]
- Standard tirzepatide pricing
- Compounded injectable tirzepatide is advertised at $268 billed monthly or $597 every three months, presented as $199 per month for the quarterly option.Sources: [11]
- Access and approval
- Services are restricted to U.S. residents age 18 or older. Telezen MD advertises all-state availability subject to medical eligibility and state regulations; an intake form does not guarantee a prescription.
- Cancellation and fees
- The refund policy requires an emailed cancellation request within 12 hours of ordering and lists a nonrefundable 4% processing fee plus a possible $35 completed-review charge.Sources: [5]
- Pharmacy responsibility
- The terms assign prescription fulfillment to independent licensed 503A compounding pharmacies, say patients cannot select the pharmacy, and state that Telezen MD itself does not compound, dispense or ship medication.Sources: [10]
Who is providing your care, and what does enrollment establish?
Telezen MD’s terms identify its operator as Telezen MD, LLC, a Florida limited liability company. They describe the platform’s role as connecting patients with licensed healthcare providers rather than promising that submitting information establishes a clinical relationship. That distinction matters before payment: ask which clinical entity will evaluate you, who will be responsible for prescribing, and how you will receive the treating professional’s identity. The consulted documentation does not identify a separate contracting clinical entity.
The website names Ozita Cooper, MD, and attributes board certifications in obesity medicine and emergency medicine to her. Its FAQ also claims LegitScript certification and exclusive relationships with U.S.-licensed medical providers and licensed U.S. pharmacies. These are useful statements to investigate, but this review did not independently verify the credentials, certification or pharmacy quality controls. A named physician on a website does not establish which professional will review every patient’s case.
The terms restrict services to U.S. residents age 18 or older. The FAQ advertises GLP-1 care in all 50 states, subject to medical eligibility and state regulations—not unconditional access in every circumstance. Before completing checkout, confirm availability for your location and intended treatment. Our guide to questions a program should answer before enrollment can help organize that conversation without treating broad geographic coverage as assurance of approval.
What will the clinician need before making a decision?
The documented intake collects health history, current medications, symptoms, goals and relevant lifestyle factors through a secure online form. The FAQ gives a general eligibility example of BMI 27 or higher with at least one weight-related health consideration, or other clinical indications under current guidelines. It expressly says meeting a BMI threshold does not guarantee approval. Treat that language as a description of Telezen MD’s screening approach, not a way to determine your own eligibility.
Laboratory requirements depend on the therapy and medical history, according to the FAQ. Some treatments may be considered from symptoms and history alone, while others may require testing. The consulted pages do not establish lab prices or clearly allocate responsibility for arranging and paying for them. Ask whether existing results can be reviewed, whether additional tests could delay a decision, and what happens financially if the evaluation cannot be completed without them.
Medication choice also remains open until clinical review. The FAQ discusses branded and compounded options when appropriate and legally permitted, but guarantees neither a particular brand nor a formulation. Published prices are much more specific for compounded plans than branded treatment. A useful consultation question is therefore: “What exact product are you proposing for me, why, and what would that option cost?” NIDDK likewise frames medication selection around health conditions, other medicines, benefits, side effects and cost.
Which advertised price would actually apply to your order?
Telezen MD’s standard page advertises GLP-1 injections “starting at $99/month.” The price grid ties that figure to compounded semaglutide billed at $297 every three months, not a $99 monthly charge. The separately offered monthly plan costs $168. Compounded tirzepatide has its own rates: $268 billed monthly or $597 every three months, advertised as $199 per month. These are different payment intervals, and the three-month label alone does not establish the quantity shipped or a minimum commitment.
The microdosing page presents another price structure. Its monthly-equivalent figures are estimates, and it says multi-month plans are paid in full at checkout or through buy-now-pay-later options. Actual pricing may vary with the medication and prescribed treatment plan. It advertises Klarna, Afterpay and Affirm, without providing financing terms in the consulted documentation. The table preserves the displayed amounts rather than treating rounded monthly equivalents as exact installment schedules.
The standard page also advertises $100 off a first order with WELCOME100, but the consulted material does not explain applicable plans, restrictions or whether discounts combine. The FAQ lists six- and twelve-month plans without documenting their prices here. Before comparing offers, request the checkout total, billing interval and next-charge date; our price questions beyond the monthly headline provide a useful checklist. Do not assume that a promotion changes later charges or applies to every plan.
| Plan | Monthly option | Quarterly option and conditions |
|---|---|---|
| Standard injectable semaglutide | $168 billed monthly | $297 every three months; advertised as $99/month |
| Standard injectable tirzepatide | $268 billed monthly | $597 every three months; advertised as $199/month |
| Semaglutide microdosing offer | $98/month | $248 quarterly; advertised estimated equivalent $82/month |
| Tirzepatide microdosing offer | $168/month | $448 quarterly; advertised estimated equivalent $149/month |
| Microdosing multi-month payment terms | Separate monthly options are displayed | Full payment at checkout or buy-now-pay-later; actual price may vary by prescription |
What is included, and which payment questions remain?
The standard GLP-1 page says plans include provider review, medication, necessary supplies such as syringes and alcohol swabs, and free expedited shipping. It also includes unlimited provider messaging and concierge support by call or text. Those are meaningful components of the advertised package. Nevertheless, an inclusion list is not the same as a complete explanation of every potential charge, especially when the refund policy separately describes processing and completed-review fees.
That policy says all orders carry a nonrefundable payment-processing fee, currently 4%, charged at purchase. It also identifies a nonrefundable $35 “doctor visit fee” when a licensed provider has reviewed the case before an eligible cancellation. Ask whether the 4% is added to the displayed plan price, where it appears before payment, and when the $35 deduction applies. The documentation does not justify assuming that the advertised package price is the final checkout total.
Telezen MD does not accept insurance. Its microdosing page advertises FSA/HSA acceptance, but the refund policy more cautiously says some services may qualify for reimbursement and makes patients responsible for confirming eligibility. Payment acceptance and reimbursement eligibility are separate questions. Ask your account administrator about the particular service and required documentation. Financing availability likewise does not establish interest rates, approval, installment amounts or cancellation handling; those details remain to be confirmed.
Can you stop future service without losing an existing payment?
The standard page promises no contracts, no membership fees, and the ability to pause, delay or cancel through the patient portal. The refund policy addresses a different issue: canceling a particular order. It requires emailing support@telezenmd.com within 12 hours of placing that order. These statements should not be collapsed into “cancel anytime for a refund.” Ask separately how to stop future charges and whether a current order remains cancelable.
The refund policy itself contains materially different boundaries. One passage permits an eligible refund, less applicable fees, if cancellation succeeds before pharmacy compounding begins. Another makes an order final and nonrefundable once any processing starts, explicitly including provider review or prescription issuance. The documentation does not resolve which provision controls a case reviewed by a clinician but not yet compounded. Written clarification before checkout is more useful than choosing whichever sentence seems most favorable.
There is a second direct conflict when treatment is declined. The FAQ promises a full refund if the provider finds therapy inappropriate or unsafe; the refund policy permits deducting $35 after a completed consultation and separately imposes the general nonrefundable processing fee. Automatic renewal, renewal cutoff dates and refunds for unused prepaid periods are also unclear. Use these questions before the next charge to request an explicit timeline and dollar-level explanation before enrolling.
Which pharmacy and formulation would you receive?
Telezen MD’s terms say it does not manufacture, compound, dispense or ship medication. They assign fulfillment to independent licensed third-party 503A compounding pharmacies. Patients cannot select the dispensing pharmacy, and partners can change for clinical, operational or regulatory reasons. No dispensing pharmacy is named in the consulted material. Before accepting a prescription, ask for the assigned pharmacy’s name, contact information, exact formulation and presentation, and who answers product-specific questions.
The standard page acknowledges that compounded medicines are not reviewed or approved by FDA for safety or efficacy. References to regulated pharmacies do not make the platform or a compounded preparation FDA approved. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not establish clinical inequivalence, but neither does the ingredient name establish that every formulation has the same evidence.
Microdosing claims warrant particular care. The consulted documentation does not establish provider-specific outcomes or demonstrate that its microdosing offerings produce fewer adverse effects or lasting results. Trials of standard regimens do not establish results for Telezen MD, compounded preparations or microdoses. Ask the clinician to explain the evidence for the actual proposal and clarify all measurement instructions with the prescriber or pharmacist. FDA has reported measurement and administration errors involving compounded GLP-1 drugs, including some associated with hospitalization.
When should delivery happen, and how quickly must you report problems?
The standard page describes provider review and possible prescribing typically within 24 hours, followed by pharmacy preparation and overnight shipping. The FAQ gives a different general sequence: about one business day for review, up to three business days for compounding when required, and about two business days of shipping after dispatch. It warns that medication type, pharmacy volume and holidays can alter timing. Neither description promises next-day arrival after completing intake.
The FAQ says some medications use temperature-controlled packaging with insulation and cold packs. The consulted documentation does not establish product-specific storage instructions, carriers or guaranteed transit windows. Ask which schedule applies to your prescription and whom to contact if tracking stalls. Our delivery-problem questions can help separate pharmacy preparation, dispatch and arrival, rather than assuming “overnight” describes the entire process.
The refund policy gives only two business days from a package being marked delivered to report a delivery problem; later claims are ineligible for replacement or reshipment. Inspect the shipment promptly and retain the relevant order and tracking information. Separately, FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy. A delivery claim deadline does not establish whether a particular product is suitable to use.
What support and guarantee remain after the first shipment?
Telezen MD says patients can message their provider through secure portal chat at any time, with responses typically within 24 hours. Unlimited messaging therefore does not promise immediate clinical attention. Educational content and community access are offered through a mobile app while someone remains actively enrolled in a medical therapy. Ask how follow-up is scheduled, who assesses tolerance and response, and what support remains available during a pause or after stopping enrollment.
The 180-day guarantee is narrower than a promise of meaningful weight loss. It offers possible reimbursement of medication fees after 180 consecutive days of full participation with no measurable weight loss; the $35 consultation fee is excluded. Required documentation includes a timestamped starting weight within seven days of program start, monthly weights for six months and a final weight using the same scale. Any measurable weight loss eliminates eligibility.
Guarantee requests must be submitted within 14 days after program completion. Telezen MD reserves the right to deny claims for noncompliance, inconsistent documentation or suspected fraud; approved refunds are processed within 30 business days to the original payment method, not guaranteed to reach a bank within that period. Published contact routes include support@telezenmd.com and 1-888-775-9343, plus an Aventura, Florida, address. Ask support to distinguish billing assistance, clinical follow-up and pharmacy responsibilities.
Questions & answers
Can I pay $99 each month for Telezen MD’s standard semaglutide plan?
The documented $99 figure is the monthly equivalent of the $297-every-three-months compounded injectable semaglutide option. The separate monthly plan is $168 billed monthly. Confirm the checkout total and applicable processing fee rather than interpreting the advertised equivalent as a monthly installment.
Does Telezen MD guarantee a prescription after I complete intake?
No. Its terms explicitly say intake submission guarantees neither a provider-patient relationship nor a prescription. A licensed professional reviews medical history and safety factors. The FAQ’s BMI example is not automatic approval, and laboratory requirements may depend on the proposed treatment and your history.
Will I receive all my money back if I am not eligible?
The public language conflicts. The FAQ promises a full refund, while the refund policy allows a $35 deduction after a completed consultation and separately describes a nonrefundable 4% processing fee. Ask Telezen MD to state the applicable refund amount in writing before payment rather than assuming either passage resolves the discrepancy.
Can I choose the pharmacy or require a particular brand?
The terms say patients cannot select the dispensing pharmacy, and pharmacy partners may change. The FAQ does not guarantee any specific brand or formulation. Ask which pharmacy and exact product would fulfill your prescription, and obtain product-specific pricing before assuming the compounded-plan rate applies to a branded option.
Does Telezen MD take insurance or guarantee FSA/HSA reimbursement?
Telezen MD says it does not accept insurance. Although its microdosing page advertises FSA/HSA acceptance, the refund policy limits its statement to some potentially eligible services and assigns confirmation to the patient. Confirm the particular expense and documentation requirements with your account administrator; acceptance alone does not settle reimbursement.
Does the 180-day guarantee refund treatment if I lose less than expected?
Not on the documented terms. The guarantee concerns no measurable weight loss after complete, consecutive participation, and any measurable loss defeats eligibility. It requires specified weight records and a timely claim, excludes the $35 consultation fee, and offers only possible reimbursement of medication fees—not a promised amount of weight loss.
Our assessment
Telezen MD gives prospective patients useful specifics: identifiable compounded-plan prices, included supplies and messaging, an intake process, and published delivery and refund policies. Its central weakness is that some of those policies do not align cleanly with the simpler marketing promises. Before paying, obtain written answers about the final charge, assigned pharmacy and formulation, renewal timing, and the refund available after clinical review or a finding of ineligibility. The documented service may suit someone seeking an online evaluation with ongoing messaging, but the public record does not independently establish credential validity, pharmacy quality or treatment outcomes. Its value is best judged by the exact care and financial terms offered to you—not the lowest monthly equivalent or the word “guarantee.”
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Telezen MD — returns refund policy ↗
- Telezen MD — official website ↗
- Telezen MD — faq ↗
- Telezen MD — contact us ↗
- Telezen MD — glp1 microdosing ↗
- Telezen MD — terms ↗
- Telezen MD — glp 1 therapy ↗